Literature DB >> 16047109

Multitracer PET imaging in Heidenhain variant of Creutzfeldt-Jakob disease.

A Thomas, J C Klein, N Galldiks, R Hilker, M Grond, A H Jacobs.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16047109     DOI： 10.1007/s00415-005-0953-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  11 in total

1.  Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Authors:  K Herholz; E Salmon; D Perani; J C Baron; V Holthoff; L Frölich; P Schönknecht; K Ito; R Mielke; E Kalbe; G Zündorf; X Delbeuck; O Pelati; D Anchisi; F Fazio; N Kerrouche; B Desgranges; F Eustache; B Beuthien-Baumann; C Menzel; J Schröder; T Kato; Y Arahata; M Henze; W D Heiss
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

Review 2.  Neuropathology of prion diseases.

Authors:  Herbert Budka
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

3.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

4.  Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry.

Authors:  B Szelies; G Weber-Luxenburger; R Mielke; G Pawlik; J Kessler; U Pietrzyk; B Bauer; W D Heiss
Journal:  Eur J Neurol       Date:  2000-07       Impact factor: 6.089

5.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

6.  Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.

Authors:  Anne Lingford-Hughes; Susan P Hume; Adrian Feeney; Ella Hirani; Safiye Osman; Vincent J Cunningham; Victor W Pike; David J Brooks; David J Nutt
Journal:  J Cereb Blood Flow Metab       Date:  2002-07       Impact factor: 6.200

7.  Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).

Authors:  Karsten Henkel; Inga Zerr; Andreas Hertel; Klaus-F Gratz; Andreas Schröter; Henriette J Tschampa; Heiner Bihl; Udalrich Büll; Frank Grünwald; Alexander Drzezga; Jörg Spitz; Sigrid Poser
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

8.  MR imaging of Creutzfeldt-Jakob disease.

Authors:  M Finkenstaedt; A Szudra; I Zerr; S Poser; J H Hise; J M Stoebner; T Weber
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

9.  In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon.

Authors:  G Sette; J C Baron; A R Young; H Miyazawa; I Tillet; L Barré; J M Travère; J M Derlon; E T MacKenzie
Journal:  Stroke       Date:  1993-12       Impact factor: 7.914

10.  Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.

Authors:  I Savic; M Ingvar; S Stone-Elander
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154
View more
  4 in total

Review 1.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.

Authors:  E-J Kim; S-S Cho; B-H Jeong; Y-S Kim; S W Seo; D L Na; M D Geschwind; Y Jeong
Journal:  Eur J Neurol       Date:  2011-11-04       Impact factor: 6.089

Review 3.  Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer's disease.

Authors:  A Winkeler; Y Waerzeggers; A Klose; P Monfared; A V Thomas; M Schubert; M T Heneka; A H Jacobs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

4.  An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD.

Authors:  Julius Obergassel; Lisa Lohmann; Sven G Meuth; Heinz Wiendl; Oliver Grauer; Christopher Nelke
Journal:  Prion       Date:  2020-12       Impact factor: 3.931
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.